These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15799221)

  • 21. Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Oct; 18(7):2394-2409. PubMed ID: 28138820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of verapamil hydrochloride microcapsules.
    Mukherjee B; Mahanti B; Panda P; Mahapatra S
    Am J Ther; 2005; 12(5):417-24. PubMed ID: 16148427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of enteric matrix microspheres prepared by emulsion-solvent evaporation using scanning electron microscopy.
    Obeidat WM; Price JC
    J Microencapsul; 2004 Feb; 21(1):47-57. PubMed ID: 14718185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA; El-Bagory I; Bayomi MA
    Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug release from tablets containing cellulose acetate phthalate as an additive or enteric-coating material.
    Lin SY; Kawashima Y
    Pharm Res; 1987 Feb; 4(1):70-4. PubMed ID: 3508533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
    Chen J; Huang GD; Tan SR; Guo J; Su ZQ
    Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride.
    Sengel CT; Hasçiçek C; Gönül N
    J Microencapsul; 2006 Mar; 23(2):135-52. PubMed ID: 16754371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tabletted microspheres containing Cynara scolymus (var. Spinoso sardo) extract for the preparation of controlled release nutraceutical matrices.
    Gavini E; Alamanni MC; Cossu M; Giunchedi P
    J Microencapsul; 2005 Aug; 22(5):487-99. PubMed ID: 16361192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of modified ethylcellulose lattices for microporous coating of osmotic tablets.
    Appel LE; Zentner GM
    Pharm Res; 1991 May; 8(5):600-4. PubMed ID: 1866374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force.
    Yao T; Yamada M; Yamahara H; Yoshida M
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1510-4. PubMed ID: 9332004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of enteric-coated microcapsules for tableting by spray-drying technique and in vitro simulation of drug release from the tablet in GI tract.
    Takenaka H; Kawashima Y; Lin SY
    J Pharm Sci; 1980 Dec; 69(12):1388-92. PubMed ID: 7463321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
    Gavini E; Sanna V; Juliano C; Giunchedi P
    J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Characterization of Chitosan Cross-Linked With Tripolyphosphate as a Sustained Release Agent in Tablets, Part I: Design of Experiments and Optimization.
    Pinto CA; Saripella KK; Loka NC; Neau SH
    J Pharm Sci; 2018 Apr; 107(4):1063-1075. PubMed ID: 29183743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.
    Patel MM
    Drug Deliv Transl Res; 2017 Apr; 7(2):312-324. PubMed ID: 28138901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release captopril microcapsules: effect of ethyl cellulose viscosity grade on the in vitro dissolution from microcapsules and tableted microcapsules.
    Singh J; Robinson DH
    J Microencapsul; 1990; 7(1):67-76. PubMed ID: 2407820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K; Picker-Freyer KM
    Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation.
    Kawashima Y; Takeuchi H; Hino T; Niwa T; Lin TL; Sekigawa F; Kawahara K
    Pharm Res; 1993 Mar; 10(3):351-5. PubMed ID: 8464806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reacetylated chitosan microspheres for controlled delivery of anti-microbial agents to the gastric mucosa.
    Portero A; Remuñán-López C; Criado MT; Alonso MJ
    J Microencapsul; 2002; 19(6):797-809. PubMed ID: 12569028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.